According to information released by the company:
"Some of these new deals are designed to bring its anti-cancer cannabis formulations and its other critical ailment formulations to the public through the FDA in the USA and more rapidly through other expanded markets around the world."One of the larger deals the company expects to sign and announce within the next few days is a business relationship with a multi-million dollar pharmaceutical technology provider. Under the terms of the agreement, Cannabis Science will work closely with the technology provider to market and sell their co-branded products on an exclusive and non-exclusive basis with this new ground breaking technology in the Medical Cannabis industry.
You can learn more about Cannabis Science Inc. at their Web site here.